ANTIROUGEURS ROSAMED
Rosacea now affects 415 million people worldwide, the majority of whom are women (70% of cases).
The origin of this physiopathology lies in the skin's hypersensitivity to external aggressions, temperature variations and UVs.
ROSAMED acts in a long-lasting way by directly targeting the source of rosacea, offering a veritable concentrate of efficacy to treat established redness.
Why prescribe it?
A range co-developed with dermatologists
Including renowned expert Pr Saurat, who has over 1,000 scientific publications to his credit.
A patented active ingredient
AngiopainTM, our patented active ingredient, has a mechanism of action that acts at the source of Rosacea. It presents a capilaroregulatory effect and helps maintain vascular stability.
An attack and maintenance range
Attack: to bring the patient back to pathology level 0.
In the background: to maintain these effects thanks to the anti-recurrence action.
Rosamed also completes the therapeutic arsenal for rosacea. The range can be used:
- as monotherapy
- in combination with lasers
- in combination with drug treatments (Ivermectin, Metronidazole)
Want to read on?
This access is reserved for professionals, registered on Pierre Fabre For Med.
To access the full content, please register or log in if you already have an account.